Evolent Health (EVH) Tops Q1 EPS by 3c ; Offers Guidance

Evolent Health (NYSE: EVH) reported Q1 EPS of ($0.02), $0.03 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $496.25 million versus the consensus estimate of $534.01 million.

GUIDANCE:

Evolent Health sees FY2026 revenue of $2.4-2.6 billion, versus the consensus of $2.5 billion.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Evolent Health (EVH) PT Lowered to $6 at Canaccord